Lanean...
New and Emerging Targeted Therapies for Pediatric Acute Myeloid Leukemia (AML)
The relapse rate for children with acute myeloid leukemia (AML) remains high despite advancements in risk classification, multi-agent chemotherapy intensification, stem cell transplantation, and supportive care guidelines. Prognosis for this subgroup of children with relapsed/refractory AML remains...
Gorde:
| Argitaratua izan da: | Children (Basel) |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
MDPI
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7072702/ https://ncbi.nlm.nih.gov/pubmed/32050659 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/children7020012 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|